Triple Antibiotic HC Ophthalmic Ointment Interactions
There are 51 drugs known to interact with Triple Antibiotic HC Ophthalmic Ointment (bacitracin / hydrocortisone / neomycin / polymyxin b ophthalmic), along with 2 disease interactions. Of the total drug interactions, 1 is major, and 50 are moderate.
- View all 51 medications that may interact with Triple Antibiotic HC Ophthalmic Ointment
- View Triple Antibiotic HC Ophthalmic Ointment disease interactions (2)
Most frequently checked interactions
View interaction reports for Triple Antibiotic HC Ophthalmic Ointment (bacitracin / hydrocortisone / neomycin / polymyxin b ophthalmic) and the medicines listed below.
- acetaminophen
- albuterol
- alpha-lipoic acid
- amlodipine
- Anti-Gas Ultra Strength (simethicone)
- Aquaphor (emollients topical)
- aspirin
- atorvastatin
- Atrovent (ipratropium)
- Augmentin (amoxicillin / clavulanate)
- Belcomp-PB (belladonna / caffeine / ergotamine / pentobarbital)
- caffeine / ergotamine
- calcium carbonate
- Calmoseptine (menthol/zinc oxide topical)
- Caltrate 600 with Iron and Vitamin D (calcium / ferrous fumarate / vitamin d)
- Fosamax (alendronate)
- ibuprofen
- Januvia (sitagliptin)
- metoprolol
- Milk of Magnesia (magnesium hydroxide)
- mupirocin topical
- omeprazole
- paroxetine
- Paxil (paroxetine)
- Tylenol (acetaminophen)
- Ventolin HFA (albuterol)
- Vitamin D3 (cholecalciferol)
- Voltaren Arthritis Pain Gel (diclofenac topical)
- Xarelto (rivaroxaban)
- Zyrtec (cetirizine)
Triple Antibiotic HC Ophthalmic Ointment disease interactions
There are 2 disease interactions with Triple Antibiotic HC Ophthalmic Ointment (bacitracin / hydrocortisone / neomycin / polymyxin b ophthalmic) which include:
Report options
More about Triple Antibiotic HC Ophthalmic Ointment (bacitracin / hydrocortisone / neomycin / polymyxin b ophthalmic)
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: ophthalmic steroids with anti-infectives
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.